← FDA Drug Approvals (Drugs@FDA)

BIVALIRUDIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 2015-07-14

Drug application

FDA Application #

ANDA090816

Application type

Abbreviated New Drug Application (Generic)

Brand name

BIVALIRUDIN

Generic name

Bivalirudin

Active ingredients

BIVALIRUDIN

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

HOSPIRA

First approval

2015-07-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown